rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-10-26
|
pubmed:abstractText |
Vision loss and cerebrovascular accidents often complicate giant cell arteritis (GCA). Antiplatelet and anticoagulant therapy reduce the risk of stroke in other populations. We sought to determine whether antiplatelet or anticoagulant therapy reduces ischemic complications in patients with GCA.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3306-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17009265-Aged,
pubmed-meshheading:17009265-Aged, 80 and over,
pubmed-meshheading:17009265-Anticoagulants,
pubmed-meshheading:17009265-Aspirin,
pubmed-meshheading:17009265-Brain Ischemia,
pubmed-meshheading:17009265-Cohort Studies,
pubmed-meshheading:17009265-Dose-Response Relationship, Drug,
pubmed-meshheading:17009265-Female,
pubmed-meshheading:17009265-Giant Cell Arteritis,
pubmed-meshheading:17009265-Hemorrhage,
pubmed-meshheading:17009265-Humans,
pubmed-meshheading:17009265-Male,
pubmed-meshheading:17009265-Middle Aged,
pubmed-meshheading:17009265-Platelet Aggregation Inhibitors,
pubmed-meshheading:17009265-Retrospective Studies,
pubmed-meshheading:17009265-Risk Factors,
pubmed-meshheading:17009265-Stroke,
pubmed-meshheading:17009265-Ticlopidine,
pubmed-meshheading:17009265-Warfarin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
|
pubmed:affiliation |
University of Minnesota, Minneapolis, USA. leex2679@umn.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|